CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|17|2276-2283

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.17, 2015-05, pp. : 2276-2283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus

By Chong Benjamin F   Mohan Chandra  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1147-1153

Informa Healthcare

Access to resources Recommend Favorite

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1441-1451

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3903-3920

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors

By  

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3019-3029

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-12 ,pp. : 2727-2740

Bentham Science Publishers

Access to resources Recommend Favorite